Home › Funds › WELCH & FORBES LLC › ABBV
WELCH & FORBES LLC position in ABBV
ABBVIE INC · Health Care
WELCH & FORBES LLC reported holding 342,782 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$89.7M, representing 1.07% of its reported portfolio and ranking #26 among its reported holdings. WELCH & FORBES LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How WELCH & FORBES LLC's ABBV position evolved
WELCH & FORBES LLC first disclosed a stake in ABBV in Q3 2023 at 395,066 shares (US$58.9M). The position peaked in Q3 2026 at 342,782 shares, worth US$89.7M. Across 13 filings, WELCH & FORBES LLC increased the stake 1 time(s), trimmed it 8 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 342,782 shares valued at US$89.7M — a reduction of -3,196 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 395.07K | $58.89M | New |
| Q4 2023 | 381.98K | $59.19M | Reduce |
| Q1 2024 | 371.78K | $67.70M | Reduce |
| Q2 2024 | 370.85K | $62.36M | Hold |
| Q3 2024 | 364.57K | $72.00M | Reduce |
| Q4 2024 | 363.55K | $64.60M | Hold |
| Q1 2025 | 354.62K | $74.30M | Reduce |
| Q2 2025 | 349.91K | $64.95M | Reduce |
| Q3 2025 | 348.37K | $80.66M | Hold |
| Q4 2025 | 345.95K | $79.05M | Reduce |
| Q1 2026 | 343.62K | $74.73M | Reduce |
| Q2 2026 | 345.98K | $87.06M | Add |
| Q3 2026 | 342.78K | $89.67M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABBV and 13F data
ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABBV
- Vanguard Group 180.78M sh · $41.31B · Q4 2025
- BlackRock Inc 149.49M sh · $37.62B · Q2 2026
- VANGUARD CAPITAL MANAGEMENT LLC 115.68M sh · $30.26B · Q3 2026
- STATE STREET CORP 82.82M sh · $21.66B · Q3 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 49.00M sh · $12.82B · Q3 2026
- Geode Capital Management 47.50M sh · $12.40B · Q3 2026
- GEODE CAPITAL MANAGEMENT, LLC 47.00M sh · $11.81B · Q2 2026
- Morgan Stanley 38.90M sh · $9.79B · Q2 2026
- Capital Research Global Investors 31.12M sh · $8.14B · Q3 2026
- Capital Research Global Investors 30.10M sh · $7.57B · Q2 2026
- Norges Bank Investment Management 25.55M sh · $6.43B · Q2 2026
- Franklin Resources 19.70M sh · $5.81B · Q3 2026
More on WELCH & FORBES LLC
FAQ
How long has WELCH & FORBES LLC held ABBV?
WELCH & FORBES LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is WELCH & FORBES LLC's current position in ABBV?
As of Q3 2026, WELCH & FORBES LLC holds 342.78K shares of ABBV (ABBVIE INC), valued at $89.67M, representing 1.07% of its reported portfolio and ranking #26.
Has WELCH & FORBES LLC been buying or selling ABBV?
In the latest 13F filing (Q3 2026), WELCH & FORBES LLC reduced its position in ABBV. The position peaked in Q3 2026 at 342.78K shares.
Which other funds hold ABBV?
Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.